GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹72 Cr | ₹45 Cr | ₹40 Cr | ₹30 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹72 Cr |
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹24 Cr |
How is Total Current Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹72 Cr | 62.49 | |
| Mar2025 | ₹45 Cr | 10.54 | |
| Mar2024 | ₹40 Cr | 36.57 | |
| Mar2023 | ₹30 Cr | 21.91 | |
| Mar2022 | ₹24 Cr | - | |
Compare Total Current Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹223.2 Cr | -2.3% | -5.6% | -37.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -2.3% |
-5.6% |
-37.4% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses